Cencora, Inc. (COR)

319.6 0.2 (0.06%)

As of 2025-10-16 16:07:33 EST

Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale and distribution company and a contract research organization, that was formed by the merger of Bergen Brunswig and AmeriSource in 2001 and renamed following numerous lawsuits related to its role in the American Opioid Epidemic. It is one of the largest pharmaceutical companies in the world and distributes generic pharmaceuticals, over-the-counter healthcare products, as well as home healthcare supplies and equipment.

Traded asNYSE: COR
ISINUS03073E1055
CIK0001140859
LEIAI8GXW8LG5WK7E9UD086
EIN233079390
SectorPharmaceutical
IndustryWholesale-Drugs, Proprietaries & Druggists' Sundries
CEORobert Mauch
Employees46,000
Fiscal Year End0930
Address1 WEST FIRST AVENUE, CONSHOHOCKEN, PA, 19428
Phone610-727-7000
Websitehttps://cencora.com/
Stock Quotes
trading_symbolregistrant_nametimepricechangepercentage_change
CORCencora, Inc.2025-10-16 16:07:33319.60.20.06
This is a preview of the latest data. Subscribe to access the full data.
Company Information
trading_symbolcentral_index_keyregistrant_nameisin_numberlei_numberein_numberexchangesic_codesic_descriptionfiscal_year_endstate_of_incorporationaddress_streetaddress_cityaddress_stateaddress_zip_codeaddress_countryaddress_country_codephone_numbermailing_addressbusiness_addressformer_nameindustryfounding_datechief_executive_officernumber_of_employeeswebsitemarket_capshares_issuedshares_outstandingdescriptionupdate_time
COR0001140859Cencora, Inc.US03073E1055AI8GXW8LG5WK7E9UD086233079390NYSE5122Wholesale-Drugs, Proprietaries & Druggists' Sundries0930DE1 WEST FIRST AVENUECONSHOHOCKENPA19428UNITED STATESUS610-727-70001 WEST FIRST AVENUE, CONSHOHOCKEN, PA, 194281 WEST FIRST AVENUE, CONSHOHOCKEN, PA, 19428AMERISOURCEBERGEN CORPPharmaceutical2001Robert Mauch46,000https://cencora.com/29,546,011,267297,324,779193,877,881Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale and distribution company and a contract research organization, that was formed by the merger of Bergen Brunswig and AmeriSource in 2001 and renamed following numerous lawsuits related to its role in the American Opioid Epidemic. It is one of the largest pharmaceutical companies in the world and distributes generic pharmaceuticals, over-the-counter healthcare products, as well as home healthcare supplies and equipment.2025-10-10 19:13:34
This is a preview of the latest data. Subscribe to access the full data.
COR Stock Price (End-of-Day)
This is a preview of the latest data. Subscribe to access the full data.
COR Stock Price (1-Minute)
This is a preview of the latest data. Subscribe to access the full data.
Market Cap
Fiscal YearMarket CapChange In Market CapPercentage Change In Market CapShares OutstandingChange In Shares OutstandingPercentage Change In Shares Outstanding
202429,546,011,2678,700,961,95641.7411193,280,140-7,432,198-3.7029
202320,845,049,3112,305,110,14512.4332200,712,338-4,956,290-2.4098
202218,539,939,1664,376,565,15130.9006205,668,628-2,464,733-1.1842
This is a preview of the latest data. Subscribe to access the full data.
Executive Compensation
Executive NameExecutive PositionFiscal YearSalaryBonusStock AwardsIncentive Plan CompensationOther CompensationTotal Compensation
Robert P. MauchChief Operating Officer, Executive Vice President20241,039,959—6,000,1272,079,919133,1879,253,192
Elizabeth S. CampbellChief Legal Officer, Executive Vice President2024721,967—5,700,5871,155,14891,3627,669,064
Steven H. CollisChief Executive Officer, Chairman, President20241,464,959—12,500,1014,101,886408,22518,475,171
James F. ClearyChief Financial Officer, Executive Vice President2024885,943—6,600,5081,417,509100,0009,003,960
Silvana BattagliaChief Human Resources Officer, Executive Vice President2024625,984—3,600,3731,001,57492,2815,320,212
This is a preview of the latest data. Subscribe to access the full data.
Employee Count
Fiscal YearEmployee Count
202446,000
202346,000
202244,000
This is a preview of the latest data. Subscribe to access the full data.
Income Statements
Fiscal Year202420232022
Revenue293,958,599,000262,173,411,000238,587,006,000
Cost Of Revenue284,048,570,000253,213,918,000230,290,639,000
Gross Profit9,910,029,0008,959,493,0008,296,367,000
Research And Development Expenses———
General And Administrative Expenses5,661,106,0005,309,984,0004,848,962,000
Operating Expenses———
Operating Income2,175,249,0002,340,731,0002,366,378,000
Net Income1,509,120,0001,745,293,0001,698,820,000
Earnings Per Share Basic7.68.628.15
Earnings Per Share Diluted7.538.538.04
Weighted Average Shares Outstanding Basic198,503,000202,511,000208,472,000
Weighted Average Shares Outstanding Diluted200,284,000204,591,000211,210,000
This is a preview of the latest data. Subscribe to access the full data.
Balance Sheet Statements
Fiscal Year202420232022
Cash And Cash Equivalents3,132,648,0002,592,051,0003,388,189,000
Marketable Securities Current———
Accounts Receivable23,871,815,00020,911,081,00018,452,675,000
Inventories18,998,833,00017,454,768,00015,556,394,000
Non Trade Receivables88,229,00077,120,000172,568,000
Other Assets Current———
Total Assets Current47,717,813,00042,798,826,00039,589,758,000
Marketable Securities Non Current———
Property Plant And Equipment2,181,410,0002,135,171,0002,135,003,000
Other Assets Non Current3,637,023,0003,418,182,0001,761,661,000
Total Assets Non Current19,383,854,00019,759,920,00016,970,858,000
Total Assets67,101,667,00062,558,746,00056,560,616,000
Accounts Payable50,942,162,00045,836,037,00040,192,890,000
Deferred Revenue———
Short Term Debt576,331,000641,344,0001,070,473,000
Other Liabilities Current2,758,560,0002,353,817,0002,214,592,000
Total Liabilities Current54,277,053,00048,831,198,00043,477,955,000
Long Term Debt4,388,076,0004,787,457,0005,702,833,000
Other Liabilities Non Current1,993,683,0001,884,733,000976,583,000
Total Liabilities Non Current-53,664,784,000-48,248,869,000-43,010,501,000
Total Liabilities612,269,000582,329,000467,454,000
Common Stock2,962,0002,948,0002,927,000
Retained Earnings5,417,139,0004,324,187,0002,977,646,000
Accumulated Other Comprehensive Income-989,118,000-1,402,607,000-1,830,970,000
Total Shareholders Equity645,938,000522,003,000-211,559,000
This is a preview of the latest data. Subscribe to access the full data.
Cash Flow Statements
Fiscal Year202420232022
Depreciation And Amortization670,642,000562,018,000319,192,000
Share Based Compensation Expense147,998,000124,624,00093,400,000
Other Non Cash Income Expense-24,032,000-3,593,000-11,781,000
Change In Accounts Receivable2,784,339,0002,711,786,0001,659,525,000
Change In Inventories1,479,599,0002,183,368,000665,370,000
Change In Non Trade Receivables11,109,000-102,201,000-49,307,000
Change In Other Assets———
Change In Accounts Payable4,968,093,0006,103,451,0003,320,725,000
Change In Other Liabilities148,533,00051,112,000-457,233,000
Cash From Operating Activities3,484,685,0003,911,334,0002,703,088,000
Purchases Of Marketable Securities———
Sales Of Marketable Securities———
Acquisition Of Property Plant And Equipment487,173,000458,359,000496,318,000
Acquisition Of Business69,771,0001,409,835,000133,814,000
Other Investing Activities-19,278,000-9,004,000-1,298,000
Cash From Investing Activities-618,096,000-2,602,465,000-368,437,000
Tax Withholding For Share Based Compensation63,500,00071,279,00038,076,000
Payments Of Dividends416,168,000398,752,000391,687,000
Issuance Of Common Stock——0
Repurchase Of Common Stock1,491,367,0001,180,728,000483,704,000
Issuance Of Long Term Debt———
Repayment Of Long Term Debt70,114,293,00078,187,891,0004,671,943,000
Other Financing Activities-12,347,000-9,413,000-10,122,000
Cash From Financing Activities-2,330,994,000-2,222,278,000-1,752,780,000
Change In Cash544,991,000-840,650,000523,411,000
Cash At End Of Period3,132,648,0002,592,051,0003,388,189,000
Income Taxes Paid603,900,000463,100,000244,400,000
Interest Paid250,100,000271,300,000219,800,000
This is a preview of the latest data. Subscribe to access the full data.
Key Metrics
Fiscal Year202420232022
Earnings Per Share7.68.628.15
Price To Earnings Ratio29.615820.878216.6049
Earnings Growth Rate-11.83295.76698.9572
Price Earnings To Growth Ratio-2.50283.62041.8538
Book Value Per Share334.9541306.0398269.0681
Price To Book Ratio0.6720.58810.503
Ebitda2,783,662,0002,770,411,0002,262,412,000
Enterprise Value46,510,814,24039,282,654,67031,597,632,760
Dividend Yield0.00930.01090.0139
Dividend Payout Ratio0.27580.22850.2306
Debt To Equity Ratio7.685610.3999-32.0162
Capital Expenditures716,881,000562,186,000291,234,000
Free Cash Flow2,767,804,0003,349,148,0002,411,854,000
Return On Equity2.33633.3435-8.03
One Year Beta-0.02450.28310.5326
Three Year Beta0.36340.48710.7926
Five Year Beta0.66880.73180.8084
This is a preview of the latest data. Subscribe to access the full data.
Insider Transactions
Insider NameRelationship To IssuerTransaction DateAmount Of SecuritiesAcquired Or DisposedSecurities Owned Following Transaction
Campbell Elizabeth SExecutive Vice President2025-10-011,886D12,824
Mauch Robert P.Director, President & CEO2025-09-183,763A44,371
Mauch Robert P.Director, President & CEO2025-09-185,097D39,274
Mauch Robert P.Director, President & CEO2025-09-183,763D18,814
COLLIS STEVEN HDirector, Executive Chairman2025-08-1912,579A322,491
This is a preview of the latest data. Subscribe to access the full data.
Senate Trading
Name Of Reporting PersonType Of Reporting PersonReport DateTransaction TypeTransaction DateOwner TypeAmount
Thomas R CarperSenator2021-12-04Sale (Full)2021-11-16Spouse$1,001 - $15,000
Thomas R CarperSenator2021-09-01Purchase2021-08-04Spouse$1,001 - $15,000
This is a preview of the latest data. Subscribe to access the full data.
House Trading
Name Of Reporting PersonReport DateStateTransaction TypeTransaction DateOwner TypeAmount
Jefferson Shreve2025-06-22IN06Sale2025-05-12—$50,001 - $100,000
Greg Landsman2025-04-08OH01Sale2025-03-27Spouse$15,001 - $50,000
Greg Landsman2024-08-14OH01Purchase2024-05-29Spouse$15,001 - $50,000
This is a preview of the latest data. Subscribe to access the full data.
Institutional Holdings
Investor NamePeriod Of ReportMarket ValueAmount Of SecuritiesPrice Per Security
Bill Few Associates, Inc.2025-09-305,498,71517,594312.5335
Carnegie Investment Counsel2025-09-30475,0461,520312.5303
LINCOLN CAPITAL CORP2025-09-307,021,07622,465312.534
HENGEHOLD CAPITAL MANAGEMENT LLC2025-09-301,275,2774,100311.0432
HALBERT HARGROVE GLOBAL ADVISORS, LLC2025-09-3010,93935312.5429
This is a preview of the latest data. Subscribe to access the full data.
Mutual Fund Holdings
Registrant NamePeriod Of ReportFund NameFund SymbolAmount Of UnitsValue In UsdPercentage Value Compared To Assets
TRUST FOR PROFESSIONAL MANAGERS2025-08-31Column Mid Cap FundCFMCX30,6588,940,179.380.8968
TRUST FOR PROFESSIONAL MANAGERS2025-08-31Column Mid Cap Select FundCFMSX91,57726,704,768.971.0289
ETF Series Solutions2025-07-31Aptus Large Cap Enhanced Yield ETFDUBS688196,823.040.0823
ETF Series Solutions2025-07-31Aptus Large Cap Upside ETFUPSD4,5181,292,509.441.5666
Pacer Funds Trust2025-07-31Pacer Trendpilot US Large Cap ETFPTLC10,6683,051,901.440.0914
This is a preview of the latest data. Subscribe to access the full data.